Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Capitan Silver Corp Announces Phase 1 Exploration Program for 2025
-
Canadian Gold Corp. Tartan South Zone First Hole Intersects 6.1 gpt Gold over 6.0m Significantly Expands Zone by 170m Vertically
-
StrategX Discovers Extensive High-Grade Graphite at Nagvaak and Expands Mineral Claims to 79,781 Hectares on the Melville Peninsula, Nunavut, Canada
-
Goldshore Discovers Shallow New Zone at Moss Gold with 17.6m of 3.03 g/t Au Including 6.8m of 7.06 g/t Au at 60m Depth Below Surface
-
American Pacific Files Updated Technical Report for its Palmer Copper-Zinc VMS Project in Southeast Alaska
-
Borealis Drills 4.48 g/t Gold over 30.5 Metres Including 15.16 g/t Gold over 6.1 Metres in Oxides at Historical Cerro Duro Deposit in Nevada
-
ProVen VCT plc: Total voting rights
-
New Claims in Vicuña District: Exploration Update
-
AlphaGraphics earns nearly $330 million nationwide in 2024
-
Awalé Hits 1.4 g/t Gold Eq. over 60 Metres at the BBM Zone, Odienné Project
-
Gunnison Copper Announces Comprehensive Financial Transaction, Including $3 million in Non-Dilutive Funding from Nuton, a Rio Tinto Venture for Nuton Stage 1 Viability Testing at the Gunnison Project
-
Promino Nutritional Sciences Inc. Announces Research Supporting Efficacy of Promino(TM): One Serving is Equivalent to 75 Grams of Whey Protein in Stimulating Muscle Protein Synthesis
-
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
-
Politecnico di Torino flies to Ethiopia for an institutional mission
-
Abcourt Announces Strategic Partnership With Groupe Minier Technica
-
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
-
Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
ROME Therapeutics Announces Publication in Nature Communications of First Large-Scale, Pan-Cancer Analysis of LINE-1 Expression Levels and Retrotransposon Activity
-
Emerita Announces Commencement of Hearings to Resolve Corruption Charges Related to Awarding of Aznalcollar Public Tender, Spain
-
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of Upcoming Institutional Investor Conferences
-
Lexicon Pharmaceuticals Announces Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain
-
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
-
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urolo
-
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
-
ArriVent BioPharma Reports Full Year 2024 Financial Results
-
enCore Energy Corp. Reports Fiscal Year 2024 Financial Results and Files Annual Report on Form 10-K
-
R/GA Goes Independent in Management and Private Equity Partnership
-
Opthea Announces Phase 2b Wet AMD Publication
-
MediPharm Labs to Sell its Hope Facility to Rubicon Organics for $4.5M
-
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference
-
Our Rescue Celebrates Female Leaders in the Fight Against Sex Trafficking and Child Exploitation to Mark International Women's Day and Women's History Month
-
ScottsMiracle-Gro to Webcast Presentation at Raymond James & Associates 46th Annual Institutional Investors Conference on March 4
-
Kroger Announces Resignation of CEO Rodney McMullen
-
Amwins Acquires Community Association Insurance Solutions, LLC
-
Nuclear Fuels Acquires TenSleep Uranium Project with Athabasca Basin-Style Mineralization in Wyoming's Powder River Basin
-
BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results
-
Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Valens Semiconductor to Participate at the 37th Annual ROTH Conference on March 17-18
-
PayCargo and Gnosis Freight to Power Container Payment Portal for Hapag-Lloyd
-
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
-
NEW FOUND GOLD STRENGTHENS BOARD OF DIRECTORS
-
Quad Completes Sale of its European Operations to Capmont
-
Square Signs' Top Signage Picks to Wrap Up Winter 2025
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Burford Reports 4Q24 and FY24 Financial Results
-
Ceragon to Participate at the 37th Annual Roth Conference
-
ModMed, a Leading Healthcare SaaS Platform, Announces Significant Majority Growth Investment from Clearlake Capital
-
Giyani Produces First Battery-Grade Manganese at its Demo Plant
-
Ligand to Participate in March Investor Conferences
-
Ninadata Unveils AI-Driven Advertising Solution for Personal Injury Law Firms Amid Rising CPC Costs

